Cite
HARVARD Citation
Valerio, M. et al. (n.d.). A phase II study of pegylated liposomal doxorubicin oxaliplatin and cyclophosphamide as second-line treatment in relapsed ovarian carcinoma. International journal of gynecological cancer. pp. 79-85. [Online].